PeptidePedia The community reference

Solid-phase peptide synthesis: difference between revisions

Diff·revision 13 → 14·19:30, 15 Nov 2024

Difference between revision 13 and revision 14 of Solid-phase peptide synthesis. 3 lines changed; the page grew by 484 bytes.

Revision 13 — 22:48, 26 Oct 2024
CDMO_Caradoc (talk)
split §Cold chain from §Storage after receipt
3,377 bytes +28
Revision 14 — 19:30, 15 Nov 2024
PreregPriya (talk)
expand §Difficult sequences
3,861 bytes +484
34| Lower resin loading | Reduces chain crowding |34| Lower resin loading | Reduces chain crowding |
3535
+36These are process choices rather than quality attributes, and they do not appear on a [[Certificate of analysis|certificate]]. Their consequences do: a sequence handled poorly gives a crude with a characteristic deletion at the difficult position, which a sufficiently specific method will resolve as a distinct related substance.{{r|usp1503}}
+37
36== References ==38== References ==
37{{reflist}}39{{reflist}}
38<ref name="merrifield1963">Merrifield RB. "Solid phase peptide synthesis. I. The synthesis of a tetrapeptide." ''Journal of the American Chemical Society'' 85(14):2149–2154 (1963). DOI:10.1021/ja00897a025.</ref>40<ref name="merrifield1963">Merrifield RB. "Solid phase peptide synthesis. I. The synthesis of a tetrapeptide." ''Journal of the American Chemical Society'' 85(14):2149–2154 (1963). DOI:10.1021/ja00897a025.</ref>
39<ref name="behrendt2016">Behrendt R, White P, Offer J. "Advances in Fmoc solid-phase peptide synthesis." ''Journal of Peptide Science'' 22(1):4–27 (2016). PMID 26785684.</ref>41<ref name="behrendt2016">Behrendt R, White P, Offer J. "Advances in Fmoc solid-phase peptide synthesis." ''Journal of Peptide Science'' 22(1):4–27 (2016). PMID 26785684.</ref>
+42<ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref>
4043
41{{DEFAULTSORT:Solid-phase peptide synthesis}}44{{DEFAULTSORT:Solid-phase peptide synthesis}}